These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 11478391

  • 1. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN.
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391
    [Abstract] [Full Text] [Related]

  • 2. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.
    Serhan CN.
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():433-55. PubMed ID: 12432935
    [Abstract] [Full Text] [Related]

  • 3. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Aug; 73(3-4):141-62. PubMed ID: 16005201
    [Abstract] [Full Text] [Related]

  • 4. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators.
    Serhan CN, Takano T, Gronert K, Chiang N, Clish CB.
    Clin Chem Lab Med; 1999 Mar; 37(3):299-309. PubMed ID: 10353476
    [Abstract] [Full Text] [Related]

  • 5. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN, Chiang N.
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [Abstract] [Full Text] [Related]

  • 6. Lipoxins in chronic inflammation.
    Kantarci A, Van Dyke TE.
    Crit Rev Oral Biol Med; 2003 Feb; 14(1):4-12. PubMed ID: 12764016
    [Abstract] [Full Text] [Related]

  • 7. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.
    O'Meara YM, Brady HR.
    Kidney Int Suppl; 1997 Mar; 58():S56-61. PubMed ID: 9067945
    [Abstract] [Full Text] [Related]

  • 8. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N, Arita M, Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 73(3-4):163-77. PubMed ID: 16125378
    [Abstract] [Full Text] [Related]

  • 9. Lipoxins: pro-resolution lipid mediators in intestinal inflammation.
    Goh J, Godson C, Brady HR, Macmathuna P.
    Gastroenterology; 2003 Apr; 124(4):1043-54. PubMed ID: 12671901
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
    Petasis NA, Akritopoulou-Zanze I, Fokin VV, Bernasconi G, Keledjian R, Yang R, Uddin J, Nagulapalli KC, Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 73(3-4):301-21. PubMed ID: 16098719
    [Abstract] [Full Text] [Related]

  • 11. Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity.
    Brady HR, Serhan CN.
    Curr Opin Nephrol Hypertens; 1996 Jan; 5(1):20-7. PubMed ID: 8834158
    [Abstract] [Full Text] [Related]

  • 12. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
    Chiang N, Gronert K, Clish CB, O'Brien JA, Freeman MW, Serhan CN.
    J Clin Invest; 1999 Aug; 104(3):309-16. PubMed ID: 10430612
    [Abstract] [Full Text] [Related]

  • 13. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?
    Serhan CN.
    Prostaglandins; 1997 Feb; 53(2):107-37. PubMed ID: 9112289
    [Abstract] [Full Text] [Related]

  • 14. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
    Papayianni A, Serhan CN, Brady HR.
    J Immunol; 1996 Mar 15; 156(6):2264-72. PubMed ID: 8690917
    [Abstract] [Full Text] [Related]

  • 15. Eicosanoids in leukocyte function.
    Serhan CN.
    Curr Opin Hematol; 1994 Jan 15; 1(1):69-77. PubMed ID: 9371262
    [Abstract] [Full Text] [Related]

  • 16. Lipoxin signaling in neutrophils and their role in periodontal disease.
    Kantarci A, Van Dyke TE.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jan 15; 73(3-4):289-99. PubMed ID: 15979867
    [Abstract] [Full Text] [Related]

  • 17. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN, Chiang N.
    ScientificWorldJournal; 2002 Jan 22; 2():169-204. PubMed ID: 12806051
    [Abstract] [Full Text] [Related]

  • 18. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
    Chiang N, Takano T, Clish CB, Petasis NA, Tai HH, Serhan CN.
    J Pharmacol Exp Ther; 1998 Nov 22; 287(2):779-90. PubMed ID: 9808710
    [Abstract] [Full Text] [Related]

  • 19. Lipoxins: novel anti-inflammatory therapeutics?
    Godson C, Brady HR.
    Curr Opin Investig Drugs; 2000 Nov 22; 1(3):380-5. PubMed ID: 11249723
    [Abstract] [Full Text] [Related]

  • 20. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
    Romano M, Maddox JF, Serhan CN.
    J Immunol; 1996 Sep 01; 157(5):2149-54. PubMed ID: 8757340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.